Supernus Prices 6M Share Public Offering at $8/Share
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a specialty pharmaceutical company announced the pricing of the underwritten public offering of 6,000,000 shares of its common stock at a price to the public of $8.00 per share. Supernus has granted the underwriters a 30-day option to purchase up to 900,000 additional shares to cover over-allotments, if any.
Jefferies & Company, Inc., Piper Jaffray & Co. and Cowen and Company, LLC are acting as joint book-running managers for the offering. Stifel Nicolaus Weisel and Lazard Capital Markets LLC are acting as co-managers.
A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state.
This offering is being made only by means of a prospectus. Copies of the preliminary prospectus or, when available, the final prospectus for this offering, may be obtained from the offices of Jefferies & Company,